Endocrinology, Vol 136, 4910-4917, Copyright © 1995 by Endocrine Society

ARTICLES

Glucagon-like peptide-1 affects gene transcription and messenger ribonucleic acid stability of components of the insulin secretory system in RIN 1046-38 cells

Y Wang, JM Egan, M Raygada, O Nadiv, J Roth and C Montrose-Rafizadeh
Laboratory of Clinical Physiology, Gerontology Research Center, National Institute on Aging, National Institutes of Health, Baltimore, Maryland 21224, USA.

It has been previously demonstrated that the enteric hormone glucagon- like peptide-1 (7-36 amide) (GLP-1) has acute effects on glucose- induced insulin secretion by RIN 1046-38 cells. In this study, we investigated the effects of extended exposure of RIN 1046-38 cells to GLP-1 and examine the mechanism by which GLP-1 synergizes with glucose in stimulating insulin secretion. Compared with cells cultured with glucose alone, incubation of cells with glucose plus 1 or 10 nM GLP-1 for 12 or 24 h significantly increased insulin release by about 3-fold, intracellular insulin content by 1.5-fold, and insulin messenger RNA (mRNA) by almost 2.5-fold. The insulinotropic effects of GLP-1 on RIN 1046-38 cells were accompanied by an up-regulation of both glucose transporter-1 (GLUT-1) and hexokinase I mRNA by about 2-fold. mRNA levels of GLUT-2 and glucokinase, which were low in controls, were unchanged by GLP-1 treatment. Treatment of cells with a transcription inhibitor, actinomycin D, demonstrated that elevated insulin mRNA levels after a GLP-1 exposure are mainly due to stabilization of the mRNA. In contrast, the elevated mRNA levels of GLUT-1 and hexokinase I are the result of increased transcription stimulated by GLP-1 exposure. Actinomycin D blunted the GLP-1 effect on insulin release but did not affect GLP-1 mediated elevation of insulin mRNA. This suggests that actinomycin D inhibits the transcription of the proteins necessary for insulin biosynthesis and insulin release, such as GLUT-1 and hexokinase I. Our study suggests that the mechanisms by which extended exposure of RIN 1046-38 cells to GLP-1 increases glucose-stimulated insulin secretion include significant up-regulation of glucose-sensing elements.

This article has been cited by other articles:

				R. W. Gelling, P. M. Vuguin, X. Q. Du, L. Cui, J. Romer, R. A. Pederson, M. Leiser, H. Sorensen, J. J. Holst, C. Fledelius, et al. Pancreatic {beta}-cell overexpression of the glucagon receptor gene results in enhanced {beta}-cell function and mass Am J Physiol Endocrinol Metab, September 1, 2009; 297(3): E695 - E707. [Abstract] [Full Text] [PDF]

				H. Liu, Y. Hu, R. W Simpson, and A. E Dear Glucagon-like peptide-1 attenuates tumour necrosis factor-{alpha}-mediated induction of plasmogen activator inhibitor-1 expression J. Endocrinol., January 1, 2008; 196(1): 57 - 65. [Abstract] [Full Text] [PDF]

				B. J. Lamont and D. J. Drucker Differential Antidiabetic Efficacy of Incretin Agonists Versus DPP-4 Inhibition in High Fat Fed Mice Diabetes, January 1, 2008; 57(1): 190 - 198. [Abstract] [Full Text] [PDF]

				X. Wang, H. Li, D. De Leo, W. Guo, V. Koshkin, I. G. Fantus, A. Giacca, C. B. Chan, S. Der, and M. B. Wheeler Gene and Protein Kinase Expression Profiling of Reactive Oxygen Species-Associated Lipotoxicity in the Pancreatic {beta}-Cell Line MIN6 Diabetes, January 1, 2004; 53(1): 129 - 140. [Abstract] [Full Text] [PDF]

				Y. Li, T. Hansotia, B. Yusta, F. Ris, P. A. Halban, and D. J. Drucker Glucagon-like Peptide-1 Receptor Signaling Modulates beta Cell Apoptosis J. Biol. Chem., January 3, 2003; 278(1): 471 - 478. [Abstract] [Full Text] [PDF]

				A. A. Hardikar, X. Y. Wang, L. J. Williams, J. Kwok, R. Wong, M. Yao, and B. E. Tuch Functional Maturation of Fetal Porcine {beta}-Cells by Glucagon-Like Peptide 1 and Cholecystokinin Endocrinology, September 1, 2002; 143(9): 3505 - 3514. [Abstract] [Full Text] [PDF]

				O. G. Chepurny, M. A. Hussain, and G. G. Holz Exendin-4 as a Stimulator of Rat Insulin I Gene Promoter Activity via bZIP/CRE Interactions Sensitive to Serine/Threonine Protein Kinase Inhibitor Ro 31-8220 Endocrinology, June 1, 2002; 143(6): 2303 - 2313. [Abstract] [Full Text] [PDF]

				J.A. Pospisilik, S.G. Stafford, H-U. Demuth, R. Brownsey, W. Parkhouse, D.T. Finegood, C.H.S. McIntosh, and R.A. Pederson Long-Term Treatment With the Dipeptidyl Peptidase IV Inhibitor P32/98 Causes Sustained Improvements in Glucose Tolerance, Insulin Sensitivity, Hyperinsulinemia, and {beta}-Cell Glucose Responsiveness in VDF (fa/fa) Zucker Rats Diabetes, April 1, 2002; 51(4): 943 - 950. [Abstract] [Full Text] [PDF]

				X. Wang, J. Zhou, M. E. Doyle, and J. M. Egan Glucagon-Like Peptide-1 Causes Pancreatic Duodenal Homeobox-1 Protein Translocation from the Cytoplasm to the Nucleus of Pancreatic {beta}-Cells by a Cyclic Adenosine Monophosphate/Protein Kinase A-Dependent Mechanism Endocrinology, May 1, 2001; 142(5): 1820 - 1827. [Abstract] [Full Text]

				W. Moritz, C. A. Leech, J. Ferrer, and J. F. Habener Regulated Expression of Adenosine Triphosphate-Sensitive Potassium Channel Subunits in Pancreatic {beta}-Cells Endocrinology, January 1, 2001; 142(1): 129 - 138. [Abstract] [Full Text] [PDF]

				A. M. F. Salapatek, P. E. MacDonald, H. Y. Gaisano, and M. B. Wheeler Mutations to the Third Cytoplasmic Domain of the Glucagon-Like Peptide 1 (GLP-1) Receptor Can Functionally Uncouple GLP-1-Stimulated Insulin Secretion in HIT-T15 Cells Mol. Endocrinol., August 1, 1999; 13(8): 1305 - 1317. [Abstract] [Full Text]

				Y. Wang, W. Lee-Kwon, J. L. Martindale, L. Adams, P. Heller, J. M. Egan, and M. Bernier Modulation of CCAAT/Enhancer-Binding Protein-{alpha} Gene Expression by Metabolic Signals in Rodent Adipocytes Endocrinology, July 1, 1999; 140(7): 2938 - 2947. [Abstract] [Full Text]

				C. Montrose-Rafizadeh, P. Avdonin, M. J. Garant, B. D. Rodgers, S. Kole, H. Yang, M. A. Levine, W. Schwindinger, and M. Bernier Pancreatic Glucagon-Like Peptide-1 Receptor Couples to Multiple G Proteins and Activates Mitogen-Activated Protein Kinase Pathways in Chinese Hamster Ovary Cells Endocrinology, March 1, 1999; 140(3): 1132 - 1140. [Abstract] [Full Text]

				J. A. Maurer and S. Wray Luteinizing Hormone-Releasing Hormone Quantified in Tissues and Slice Explant Cultures of Postnatal Rat Hypothalami Endocrinology, February 1, 1999; 140(2): 791 - 799. [Abstract] [Full Text]

				J. A. Maurer and S. Wray Luteinizing Hormone-Releasing Hormone (LHRH) Neurons Maintained in Hypothalamic Slice Explant Cultures Exhibit a Rapid LHRH mRNA Turnover Rate J. Neurosci., December 15, 1997; 17(24): 9481 - 9491. [Abstract] [Full Text] [PDF]